Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)

Exclusion Criteria

• •Patients who have received NUEDEXTA® in the past 1 year
• •Patients with the diagnosis of Severe Depressive Disorder that would interfere with the conduct of the study
• •Patients who have a history of schizophrenia spectrum and other psychotic disorders
• •Patients with co-existent clinically significant or unstable systemic diseased that could confound the interpretation of the safety results of the study (e.g.,malignancy, poorly controlled diabetes, poorly controlled hypertension, unstable pulmonary, renal or hepatic disease, unstable ischemic cardiac disease, dilated cardiomyopathy, or unstable valvular heart disease)
• •Patients with myasthenia gravis